Qube Research & Technologies (QRT)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-212,921
| Closed | -$40.7M | – | 3489 |
|
|
2026
Q1 | $39M | Buy |
+212,921
| New | +$39.2M | 0.04% | 532 |
|
|
2025
Q4 | – | Sell |
-121,607
| Closed | -$19.9M | – | 3683 |
|
|
2025
Q3 | $17M | Sell |
121,607
-621,702
| -84% | -$84M | 0.02% | 986 |
|
|
2025
Q2 | $93.4M | Sell |
743,309
-483,400
| -39% | -$60.2M | 0.09% | 269 |
|
|
2025
Q1 | $168M | Buy |
1,226,709
+135,867
| +12% | +$19.4M | 0.19% | 120 |
|
|
2024
Q4 | $167M | Buy |
1,090,842
+741,497
| +212% | +$125M | 0.22% | 96 |
|
|
2024
Q3 | $67.7M | Buy |
349,345
+335,113
| +2,355% | +$70.1M | 0.1% | 255 |
|
|
2024
Q2 | $3.3M | Sell |
14,232
-86,613
| -86% | -$18.8M | 0.01% | 1445 |
|
|
2024
Q1 | $21.7M | Buy |
+100,845
| New | +$23.6M | 0.03% | 544 |
|
|
2023
Q4 | – | Sell |
-6,328
| Closed | -$1.63M | – | 4343 |
|
|
2023
Q3 | $1.63M | Sell |
6,328
-42,041
| -87% | -$11.2M | ﹤0.01% | 1487 |
|
|
2023
Q2 | $13.8M | Buy |
+48,369
| New | +$14.4M | 0.05% | 445 |
|
|
2023
Q1 | – | Sell |
-228,626
| Closed | -$63.3M | – | 2550 |
|
|
2022
Q4 | $63.3M | Buy |
+228,626
| New | +$64.6M | 0.34% | 48 |
|
|
2022
Q3 | – | Sell |
-18,881
| Closed | -$3.85M | – | 2517 |
|
|
2022
Q2 | $3.85M | Sell |
18,881
-143,066
| -88% | -$29.2M | 0.03% | 578 |
|
|
2022
Q1 | $34.1M | Buy |
161,947
+146,864
| +974% | +$31.9M | 0.29% | 67 |
|
|
2021
Q4 | $3.62M | Sell |
15,083
-44,123
| -75% | -$11.3M | 0.03% | 647 |
|
|
2021
Q3 | $16.8M | Sell |
59,206
-17,445
| -23% | -$5.72M | 0.21% | 109 |
|
|
2021
Q2 | $26.5M | Buy |
+76,651
| New | +$23.2M | 0.3% | 53 |
|
|
2021
Q1 | – | Sell |
-28,151
| Closed | -$6.89M | – | 1918 |
|
|
2020
Q4 | $6.89M | Buy |
28,151
+8,045
| +40% | +$2.08M | 0.1% | 235 |
|
|
2020
Q3 | $5.7M | Sell |
20,106
-30,278
| -60% | -$8.44M | 0.08% | 318 |
|
|
2020
Q2 | $13.5M | Buy |
50,384
+47,076
| +1,423% | +$14.2M | 0.2% | 118 |
|
|
2020
Q1 | $1.05M | Buy |
+3,308
| New | +$1M | 0.04% | 376 |
|
|
2019
Q3 | – | Sell |
-10,176
| Closed | -$2.38M | – | 260 |
|
|
2019
Q2 | $2.38M | Buy |
+10,176
| New | +$2.35M | 0.57% | 36 |
|
|
2018
Q4 | – | Sell |
-10,440
| Closed | -$3.69M | – | 359 |
|
|
2018
Q3 | $3.69M | Buy |
10,440
+9,429
| +933% | +$3.25M | 0.49% | 45 |
|
|
2018
Q2 | $293K | Sell |
1,011
-237
| -19% | -$66.6K | 0.18% | 123 |
|
|
2018
Q1 | $341K | Buy |
+1,248
| New | +$387K | 0.13% | 96 |
|
Other funds holding BIIB
Qube Research & Technologies (QRT)'s BIIB Position: Q2 2026 in Review
Qube Research & Technologies (QRT) sold out of Biogen (BIIB) in Q2 2026, closing a stake of 212,921 shares — an estimated $40.7M sold.
Qube Research & Technologies (QRT) first reported a position in BIIB in Q1 2018 and held it in 24 quarters. The position peaked at $168M in Q1 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Qube Research & Technologies (QRT) reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 212,921 Biogen shares in Q2 2026, an estimated $40.7M.
- Qube Research & Technologies (QRT) first reported a position in Biogen in Q1 2018 and held it in 24 quarters.
- Qube Research & Technologies (QRT)'s Biogen position peaked at $168M in Q1 2025.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.